Follow up post: Ifenprodil for IPF and Chronic Cough has always been Algernon's strongest drug candidate since its purchase from Nash Pharmaceuticals back in 2018. It was considered to be 10% of the total value of the purchase not including handing over 50% of Algernon to Nash Pharmaceuticals in the reverse takeover. followed up with massive dilution. Now the company has come to another
...more